Abpro Holdings, Inc.

Abpro Holdings, Inc., trading under the ticker ACAB, is a biopharmaceutical-focused blank check company that filed a Form 10-Q with the SEC on May 22, 2023, accession number 0001193125-23-150482, reflecting its status as a reporting company navigating the post-IPO search phase within the life sciences and biotechnology sector. The filing provides a quarterly snapshot of the company's financial position as it pursues a business combination target aligned with its biopharma mandate. SPAC vehicles in this space have drawn sustained attention from institutional investors tracking therapeutic and drug-development deal flow. Sign up for a SpacDesk account to access full filings, deal timelines, and real-time SPAC analytics for ACAB and hundreds of other active vehicles.